We identify acyl-CoA synthetase long-chain family member (ACSL4) as an miR-211 target, explaining the observed downstream effects of miR-211 on lipid metabolism through a tumor suppressive lipid phenotype of reduced long-chain fatty acids and increased polyunsaturated fatty acids. This evidence concerns the gene ACSL4 and neoplasm.